Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist . (2021). Journal of Cancer Research Updates, 1(1), 69-77. https://doi.org/10.6000/1929-2279.2012.01.01.11